Adoption of BCMA Therapies in Emerging Markets
The adoption of BCMA therapies in emerging markets is gaining momentum as countries invest in healthcare infrastructure and establish supportive policies. As more partnerships are formed and innovative pricing strategies are implemented, emerging markets are expected to play a growing role
